Clearstead Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

Clearstead Trust’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64K	Hold	5,064	–	–	0.01%	290
2025 Q4	$79.9K	Hold	5,064	–	–	0.01%	275
2025 Q3	$60.6K	Hold	5,064	–	–	0.01%	296
2025 Q2	$38.3K	Hold	5,064	–	–	0.01%	341
2025 Q1	$28K	Hold	5,064	–	–	0.01%	319
2024 Q4	$29.1K	Hold	5,064	–	–	0.01%	295
2024 Q3	$52.5K	Hold	5,064	–	–	0.01%	241
2024 Q2	$65.7K	Hold	5,064	–	–	0.02%	218
2024 Q1	$88.4K	Hold	5,064	–	–	0.02%	197
2023 Q4	$47.7K	Hold	5,064	–	–	0.01%	239
2023 Q3	$56.6K	Hold	5,064	–	–	0.02%	213
2023 Q2	$108K	Hold	5,064	–	–	0.03%	172
2023 Q1	$205K	Hold	5,064	–	–	0.07%	124
2022 Q4	$236K	Hold	5,064	–	–	0.08%	117
2022 Q3	$263K	Buy	+5,064	New	+$296K	0.09%	106

Other funds holding ENTA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SSC

Spruce Street Capital New York $416M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Clearstead Trust's ENTA Position: Q1 2026 in Review

Clearstead Trust held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 5,064 shares worth $64K. The position accounts for 0.01% of the portfolio, ranked #290.

Clearstead Trust first reported a position in ENTA in Q3 2022 and has held it in 15 quarters since. The position peaked at $263K in Q3 2022. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

Clearstead Trust held 5,064 shares of Enanta Pharmaceuticals worth $64K as of Q1 2026.
Clearstead Trust left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
Enanta Pharmaceuticals made up 0.01% of Clearstead Trust's portfolio in Q1 2026, its #290 holding.
Clearstead Trust first reported a position in Enanta Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
Clearstead Trust's Enanta Pharmaceuticals position peaked at $263K in Q3 2022.
132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.